Exploring the medical cannabis prescribing behaviours of New Zealand physicians

Simple item page
dc.contributor.authorManoharan R
dc.contributor.authorYoung J
dc.contributor.authorKemper, Joya A.
dc.date.accessioned2022-11-06T19:52:03Z
dc.date.available2022-11-06T19:52:03Z
dc.date.issued2022en
dc.date.updated2022-10-09T22:06:11Z
dc.description.abstractIntroduction: Many countries are changing their regulations for prescribing medical cannabis. As gatekeepers, physicians significantly impact patient access to cannabis treatments. It is important to explore how physicians view prescribing cannabis in terms of their existing beliefs, knowledge, possible concerns and personal perceptions. Methods: Individual, semi-structured telephone interviews were undertaken with 14 New Zealand physicians from various specialties. The interviews were thematically analysed using a phenomenological approach. Results: The physician–patient relationship was of extreme importance in making prescription decisions, driven largely by trust in the patient. Barriers to prescribing included concern over possible side effects, the quality and standardisation of medication, uncertainty about indications and equity concerns from the high cost for lower socio-economic patients. Some physicians held concerns over their liability and risks to their reputation if issues arose for patients. Discussion and Conclusion: The way physicians regard prescribing medical cannabis is based on their personal beliefs and knowledge built up over their medical career. It is important that these are taken into consideration in the design of future guidelines to help alleviate uncertainties and reduce barriers for informed prescribing. While our research and previous research find that physicians generally will follow clinical guidelines based on institutional logics (i.e. the standardised approach to medicine), we find that physicians often allow their personal construals to determine their perceptions and prescribing behaviour to a considerable extent when they practice medicine. Our findings have implications for Continuing Medical Education, marketing and regulation for medical cannabis, especially about the wording of guideline adherence.en
dc.identifier.citationManoharan R, Kemper J, Young J (2022). Exploring the medical cannabis prescribing behaviours of New Zealand physicians. Drug and Alcohol Review. 41(6). 1355-1366.en
dc.identifier.doihttp://doi.org/10.1111/dar.13476
dc.identifier.issn0959-5236
dc.identifier.issn1465-3362
dc.identifier.urihttps://hdl.handle.net/10092/104699
dc.languageeng
dc.language.isoenen
dc.publisherWileyen
dc.rightsAll rights reserved unless otherwise stateden
dc.rights.urihttp://hdl.handle.net/10092/17651en
dc.subjectmedicinal cannabisen
dc.subjectprescribing behaviouren
dc.subjectpersonal construalsen
dc.subject.anzsrcFields of Research::42 - Health sciences::4208 - Traditional, complementary and integrative medicine::420899 - Traditional, complementary and integrative medicine not elsewhere classifieden
dc.subject.anzsrcFields of Research::42 - Health sciences::4203 - Health services and systems::420304 - General practiceen
dc.titleExploring the medical cannabis prescribing behaviours of New Zealand physiciansen
dc.typeJournal Articleen
uc.collegeUC Business School
uc.departmentManagement, Marketing and Entrepreneurship
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
DAR_2022 Accepted Version.pdf
Size:
339.96 KB
Format:
Adobe Portable Document Format
Description:
Accepted version
Download
Collections
Business: Journal Articles